Dyne Therapeutics (DYN) Accumulated Depreciation (2019 - 2026)

Dyne Therapeutics' Accumulated Depreciation history runs 8 years deep, the most recent figure standing at $9.2 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation rose 27.78% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $9.2 million (up 27.78% YoY), while the FY2025 annual figure was $8.7 million, up 28.76% from the prior year.
• Accumulated Depreciation was $9.2 million for Q1 2026 at Dyne Therapeutics, up from $8.7 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $9.2 million in Q1 2026 to a low of $2.4 million in Q1 2022.
• Historically, Accumulated Depreciation has averaged $5.7 million across 5 years, with a median of $5.7 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Accumulated Depreciation jumped 95.3% in 2022, then gained 25.98% in 2025.
• A 5-year view of Accumulated Depreciation shows it stood at $3.6 million in 2022, then jumped by 45.72% to $5.3 million in 2023, then increased by 28.08% to $6.8 million in 2024, then climbed by 28.76% to $8.7 million in 2025, then gained by 5.13% to $9.2 million in 2026.
• The last three Accumulated Depreciation figures came in at $9.2 million (Q1 2026), $8.7 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.